FACTORS IMPACTING ON ACCESS TO CLOFAZIMINE IN KWAZULU NATAL, SOUTH AFRICA TO SUPPORT ROLL OUT OF THE UPDATED 2016 DRUG RESISTANT TUBERCULOSIS GUIDELINES

2017 ◽  
Vol 73 (11) ◽  
Author(s):  
Nirupa Misra ◽  
P. Naidoo ◽  
N. Padaytchi
PLoS ONE ◽  
2009 ◽  
Vol 4 (11) ◽  
pp. e7778 ◽  
Author(s):  
Thomas R. Ioerger ◽  
Sunwoo Koo ◽  
Eun-Gyu No ◽  
Xiaohua Chen ◽  
Michelle H. Larsen ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0181797 ◽  
Author(s):  
Thandi Kapwata ◽  
Natashia Morris ◽  
Angela Campbell ◽  
Thuli Mthiyane ◽  
Primrose Mpangase ◽  
...  

2011 ◽  
Vol 17 (10) ◽  
pp. 1942-1945 ◽  
Author(s):  
Max R. O’Donnell ◽  
Jennifer Zelnick ◽  
Lise Werner ◽  
Iqbal Master ◽  
Marian Loveday ◽  
...  

2020 ◽  
Vol 189 (7) ◽  
pp. 735-745
Author(s):  
Kristin N Nelson ◽  
Neel R Gandhi ◽  
Barun Mathema ◽  
Benjamin A Lopman ◽  
James C M Brust ◽  
...  

Abstract Patterns of transmission of drug-resistant tuberculosis (TB) remain poorly understood, despite over half a million incident cases worldwide in 2017. Modeling TB transmission networks can provide insight into drivers of transmission, but incomplete sampling of TB cases can pose challenges for inference from individual epidemiologic and molecular data. We assessed the effect of missing cases on a transmission network inferred from Mycobacterium tuberculosis sequencing data on extensively drug-resistant TB cases in KwaZulu-Natal, South Africa, diagnosed in 2011–2014. We tested scenarios in which cases were missing at random, missing differentially by clinical characteristics, or missing differentially by transmission (i.e., cases with many links were under- or oversampled). Under the assumption that cases were missing randomly, the mean number of transmissions per case in the complete network needed to be larger than 20, far higher than expected, to reproduce the observed network. Instead, the most likely scenario involved undersampling of high-transmitting cases, and models provided evidence for super-spreading. To our knowledge, this is the first analysis to have assessed support for different mechanisms of missingness in a TB transmission study, but our results are subject to the distributional assumptions of the network models we used. Transmission studies should consider the potential biases introduced by incomplete sampling and identify host, pathogen, or environmental factors driving super-spreading.


BMJ Open ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. e031663
Author(s):  
Nomonde Ritta Mvelase ◽  
Yusentha Balakrishna ◽  
Keeren Lutchminarain ◽  
Koleka Mlisana

ObjectivesSouth Africa ranks among the highest drug-resistant tuberculosis (DR-TB) burdened countries in the world. This study assessed the changes in resistance levels in culture confirmed Mycobacterium tuberculosis (MTB) in the highest burdened province of South Africa during a period where major changes in diagnostic algorithm were implemented.SettingThis study was conducted at the central academic laboratory of the KwaZulu-Natal province of South Africa.ParticipantsWe analysed data for all MTB cultures performed in the KwaZulu-Natal province between 2011 and 2014. The data were collected from the laboratory information system.ResultsOut of 88 559 drug susceptibility results analysed, 18 352 (20.7%) were resistant to rifampicin (RIF) and 19 190 (21.7%) showed resistance to isoniazid (INH). The proportion of rifampicin resistant cases that were mono-resistant increased from 15.3% in 2011 to 21.4% in 2014 while INH mono-resistance (IMR) showed a range between 13.8% and 21.1%. The multidrug-resistant tuberculosis (MDR-TB) rates increased from 18.8% to 23.9% and the proportion of MDR-TB cases that had extensively drug-resistant tuberculosis remained between 10.2% and 11.1%. Most drug resistance was found in females between the ages of 15 and 44 years and the northern districts bordering high MDR-TB regions had the highest MDR-TB rates.ConclusionOur findings show increasing RIF mono-resistance (RMR) and a substantial amount of IMR. This highlights a need for an initial test that detects resistance to both these drugs so as to avoid using RIF monotherapy during continuous phase of treatment in patients with IMR. Furthermore, addition of INH will benefit patients with RMR. Although DR-TB is widespread, HIV and migration influence its distribution; therefore, TB control strategies should include interventions that target these aspects.


PLoS ONE ◽  
2015 ◽  
Vol 10 (9) ◽  
pp. e0135003 ◽  
Author(s):  
Abraham J. Niehaus ◽  
Koleka Mlisana ◽  
Neel R. Gandhi ◽  
Barun Mathema ◽  
James C. M. Brust

Sign in / Sign up

Export Citation Format

Share Document